Loading…
Based on limited metadata with no full letter text available, the FDA issued a warning letter to Pharmacy Direct, PDU on May 18, 2018, regarding an unspecified product category classified as "Other." Without access to the detailed subject line and specific violation count, the exact nature of the compliance issues cannot be determined from this metadata alone. The issuing office is also unknown, which limits clarity on the specific regulatory division overseeing this action. To understand the full scope and details of the violations, the complete warning letter text would be needed.